Research Interests
The Rawls Lab studies how drugs like cocaine, opioids, and synthetic “bath salts” impact the brain. The team focuses on understanding how certain brain proteins, particularly GLT-1, play a role in substance use disorders. Their research has shown that clavulanic acid, an FDA-approved drug, can increase GLT-1 activity and reduce addiction-related effects of opioids and psychostimulants like cocaine and methamphetamine. Furthermore, the lab investigates how targeting immune molecules, such as interleukins and chemokines, can help reduce mood-related behaviors like depression and anxiety, and drug-related effects, such as physical dependence. These studies offer new insights into potential treatments for substance use disorders and related mental health conditions.
Education, Training & Credentials
- NIDA Postdoctoral Fellowship, Lewis Katz School of Medicine at Temple University, 2000-2002
- PhD, East Carolina University School of Medicine, 1999
- BS, Chemistry, East Carolina University, 1990
Memberships
- American Association for Cancer Research (AACR)
- American Association for the Advancement of Science (AAAS)
Honors & Awards
- American Association for Cancer Research (AACR)
- American Association for the Advancement of Science (AAAS)